Lucas Ward
Stock Analyst at Ascendiant Capital
(0.61)
# 3,861
Out of 4,836 analysts
15
Total ratings
33.33%
Success rate
-41.87%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.6 → $6.2 | $2.31 | +168.40% | 3 | Apr 15, 2025 | |
| LIQT LiqTech International | Reiterates: Buy | $3.2 → $3.4 | $1.58 | +115.20% | 4 | Apr 7, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.69 | +279.40% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $7.00 | +6,771.43% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $6.46 | +41,695.67% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $144 | $2.32 | +6,120.30% | 1 | Oct 2, 2023 |
Vivos Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $6.6 → $6.2
Current: $2.31
Upside: +168.40%
LiqTech International
Apr 7, 2025
Reiterates: Buy
Price Target: $3.2 → $3.4
Current: $1.58
Upside: +115.20%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.69
Upside: +279.40%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $7.00
Upside: +6,771.43%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $6.46
Upside: +41,695.67%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $144
Current: $2.32
Upside: +6,120.30%